Table 1.
Demographics of study participants.
| Participants | Hematological cancer | Solid cancer | Healthy Control | Total | ||||
|---|---|---|---|---|---|---|---|---|
| Total | Multiple Myeloma | Non-MM hematological | Total | Breast Cancer | Other solid | |||
| N | 79 | 64 | 15 | 142 | 56 | 86 | 352 | 573 |
| Age | ||||||||
| Mean (SD) | 65.2 (9.8) | 65.9 (8.7) | 62.0 (13.3) | 63.7 (9.0) | 62.4 (9.0) | 64.5 (8.9) | 47.0 (14.0) | 53.4(14.7) |
| Range | 28 - 84 | 43 - 84 | 28 - 81 | 41 - 81 | 43 - 76 | 41 - 81 | 19-77 | 19 - 84 |
| Sex | ||||||||
| Female | 44 (55.7%) | 37 (57.8%) | 7 (46.7%) | 107 (75.4%) | 56 (100.0%) | 51 (59.3%) | 258 (73.3%) | 409 (71.4%) |
| Male | 35 (44.3%) | 27 (42.2%) | 8 (53.3%) | 35 (24.6%) | 0 (0.0%) | 35 (40.7%) | 94 (26.7%) | 164 (28.6%) |
| Race | ||||||||
| American Indian or Alaska Native | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1 (0.3%) | 1 (0.2%) |
| Asian | 3 (3.8%) | 3 (4.7%) | 0 (0.0%) | 3 (2.1%) | 1 (1.8%) | 2 (2.3%) | 48 (13.6%) | 54 (9.4%) |
| Black or African American | 11 (13.9%) | 11 (17.2%) | 0 (0.0%) | 2 (1.4%) | 1 (1.8%) | 1 (1.2%) | 24 (6.8%) | 37 (6.5%) |
| Caucasian | 54 (68.4%) | 39 (60.9%) | 15 (100.0%) | 136 (95.8%) | 53 (94.6%) | 83 (96.5%) | 245 (69.6%) | 435 (75.9%) |
| Multirace | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 1 (0.7%) | 1 (1.8%) | 0 (0.0%) | 14 (4.0%) | 15 (2.6%) |
| Other | 11 (13.9%) | 11 (17.2%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 16 (4.5%) | 27 (4.7%) |
| Unknown | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 4 (1.1%) | 4 (0.7%) |
| Ethnicity | ||||||||
| Hispanic or Latino | 3 (3.8%) | 3 (4.7%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 24 (6.8%) | 27 (4.7%) |
| Not Hispanic or Latino | 23 (29.1%) | 9 (14.1%) | 14 (93.3%) | 142 (100.0%) | 56 (100.0%) | 86 (100.0%) | 328 (93.2%) | 493 (86.0%) |
| Not Reported | 53 (67.1%) | 52 (81.2%) | 1 (6.7%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 53 (9.2%) |
| Dose | ||||||||
| 2 | 24 (25.8%) | 24 (32.9%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) | 31 (7.4%) | 55 (8.1%) |
| 3 | 38 (40.9%) | 34 (46.6%) | 4 (20.0%) | 26 (16.1%) | 13 (20.3%) | 13 (13.4%) | 244 (58.0%) | 308 (45.6%) |
| 4 | 23 (24.7%) | 13 (17.8%) | 10 (50.0%) | 41 (25.5%) | 14 (21.9%) | 27 (27.8%) | 82 (19.5%) | 146 (21.6%) |
| 5 | 8 (8.6%) | 2 (2.7%) | 6 (30.0%) | 94 (28.4%) | 37 (57.8%) | 57 (58.8%) | 64 (15.2%) | 166 (24.6%) |
Data are n (%) where n represents the number of participants in each group. Due to rounding, not all variables add up to 100%.